| 01/11 | RELIEF, NEURORX AND QUANTUM LEAP ANN : aviptadil) in the I-SPY COVID-19 Trial | PU |
| 01/11 | NEURORX, RELIEF, AND QUANTUM LEAP AN : aviptadil) in the I-SPY COVID-19 Trial | PR |
| 2020 | RELIEF THERAPEUTICS : and NeuroRx Conclude Enrollment in their Phase 2b/3 Trial .. | PU |
| 2020 | NEURORX : and Relief Conclude Enrollment in their Phase 2b/3 Trial of RLF-100&tr.. | PR |
| 2020 | RELIEF THERAPEUTICS : Appoints Chris L.J.J. Stijnen as Chief Commercial Officer | PU |
| 2020 | RELIEF THERAPEUTICS : Announces Results of Extraordinary General Meeting of THER.. | PU |
| 2020 | RELIEF THERAPEUTICS : Announces Results of Extraordinary General Meeting of THER.. | EQ |
| 2020 | RELIEF THERAPEUTICS : and NeuroRx Meet 165 Patient Enrollment Target in Phase 2b.. | PU |
| 2020 | CORRECTION : NeuroRx and Relief announce initial successful results from expande.. | PU |
| 2020 | CORRECTION : NeuroRx and Relief announce initial successful results from expande.. | EQ |
| 2020 | NEURORX AND RELIEF ANNOUNCE INITIAL : 72% survival seen in ICU patients | PR |
| 2020 | NEURORX AND RELIEF ANNOUNCE INITIAL : 72% survival seen in ICU patients | PU |
| 2020 | NEURORX AND RELIEF ANNOUNCE INITIAL : 72% survival seen in ICU patients | EQ |
| 2020 | RELIEF THERAPEUTICS : Announces Notice of Extraordinary General Meeting of THERA.. | PU |
| 2020 | RELIEF THERAPEUTICS : Announces Notice of Extraordinary General Meeting of THERA.. | EQ |
| 2020 | RELIEF THERAPEUTICS : Selects CRO and CDMO for RLF-100TM in Europe | PU |
| 2020 | RELIEF THERAPEUTICS : Selects CRO and CDMO for RLF-100TM in Europe | EQ |
| 2020 | NEURORX : and Relief Therapeutics announce enrollment of 150 patients in phase 2.. | PR |
| 2020 | RELIEF THERAPEUTICS : with Partner NeuroRx, Announces Enrollment of 150 Patients.. | PU |
| 2020 | RELIEF THERAPEUTICS : with Partner NeuroRx, Announces Enrollment of 150 Patients.. | EQ |
| 2020 | RELIEF THERAPEUTICS AND NEURORX ANNO : Trial is on track to complete enrollment .. | PU |
| 2020 | NEURORX AND RELIEF THERAPEUTICS ANNO : Trial is on track to complete enrollment .. | PR |
| 2020 | RELIEF THERAPEUTICS AND NEURORX ANNO : Trial is on track to complete enrollment .. | EQ |
| 2020 | RELIEF THERAPEUTICS : Appoints J. Paul Waymack, M.D., Sc.D. as Consultant to Str.. | PU |
| 2020 | RELIEF THERAPEUTICS : Appoints J. Paul Waymack, M.D., Sc.D. as Consultant to Str.. | EQ |
| 2020 | RELIEF THERAPEUTICS : NeuroRx and Relief announce topline efficacy data from pat.. | PU |
| 2020 | NEURORX : and Relief announce topline efficacy data from patients treated with R.. | PR |
| 2020 | RELIEF THERAPEUTICS : NeuroRx and Relief announce topline efficacy data from pat.. | EQ |
| 2020 | RELIEF THERAPEUTICS : Appoints Industry Veteran, Jack Weinstein, as Chief Financ.. | EQ |
| 2020 | RELIEF THERAPEUTICS : NeuroRx and Relief Therapeutics Establish Supply and Distr.. | EQ |
| 2020 | RELIEF THERAPEUTICS : Announces Capital Increase from its Final Tranche of the S.. | PU |
| 2020 | RELIEF THERAPEUTICS : Announces Capital Increase from its Final Tranche of the S.. | EQ |
| 2020 | RELIEF THERAPEUTICS : partner NeuroRx submits request for Emergency Use Authoriz.. | PU |
| 2020 | RELIEF THERAPEUTICS : partner NeuroRx submits request for Emergency Use Authoriz.. | EQ |
| 2020 | NEURORX : submits request for Emergency Use Authorization for RLF-100™ (av.. | PR |
| 2020 | RELIEF THERAPEUTICS : and NeuroRx Announce Partnership for Global Commercializat.. | PU |
| 2020 | RELIEF THERAPEUTICS : and NeuroRx Announce Partnership for Global Commercializat.. | PR |
| 2020 | RELIEF THERAPEUTICS : and NeuroRx Announce Partnership for Global Commercializat.. | EQ |
| 2020 | RELIEF THERAPEUTICS : Condensed consolidated interim financial statements for th.. | PU |
| 2020 | RELIEF THERAPEUTICS : Reports Half-Year 2020 Results | PU |
| 2020 | RELIEF THERAPEUTICS : Reports Half-Year 2020 Results | EQ |
| 2020 | RELIEF THERAPEUTICS : Appoints Gilles Della Corte, M.D. as Chief Medical Officer | PU |
| 2020 | RELIEF THERAPEUTICS : Appoints Gilles Della Corte, M.D. as Chief Medical Officer | EQ |
| 2020 | RELIEF THERAPEUTICS : Announces Successful Up-listing from OTC Pink to OTCQB and.. | PU |
| 2020 | RELIEF THERAPEUTICS : Announces Successful Up-listing from OTC Pink to OTCQB and.. | EQ |
| 2020 | RELIEF THERAPEUTICS : FDA grants inhaled use IND for RLF-100 (aviptadil) to trea.. | PR |
| 2020 | RELIEF THERAPEUTICS : RLF-100 (aviptadil) clinical trial showed rapid recovery f.. | BU |
| 2020 | RELIEF THERAPEUTICS : RLF-100 (aviptadil) clinical trial showed rapid recovery f.. | PR |
| 2020 | RELIEF THERAPEUTICS : FDA grants Expanded Access Protocol to RLF-100 (Aviptadil).. | BU |
| 2020 | FDA GRANTS EXPANDED ACCESS PROTOCOL : Currently in development by NeuroRx and R.. | PR |
| 2020 | RELIEF THERAPEUTICS : NeuroRx and Relief Therapeutics Announce Data Monitoring .. | BU |
| 2020 | RELIEF THERAPEUTICS : and NeuroRx Announce Enrollment of First Patients with RLF.. | BU |
| 2020 | Relief Therapeutics Announces Filing of IND for Phase 2/3 Clinical Trial of I.. | GL |
| 2020 | RELIEF THERAPEUTICS HOLDING (RLF : SIX) Drug Aviptadil Enters FDA Trial at NYU L.. | BU |
| 2020 | RELIEF THERAPEUTICS (RLF : SIX) Drug Aviptadil Enters FDA Trial at Thomas Jeffer.. | BU |
| 2020 | RELIEF THERAPEUTICS (RLF : SIX) Drug Aviptadil Enters FDA Trial at University of.. | BU |
| 2020 | RELIEF THERAPEUTICS HOLDING SA : Announces the Closing of its Share Exchange Agr.. | BU |
| 2020 | RELIEF THERAPEUTICS : and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVI.. | PR |
| 2020 | RELIEF THERAPEUTICS HOLDING SA (SIX : RLF) Announces Plans to Test Aviptadil for.. | BU |
| 2020 | RELIEF THERAPEUTICS HOLDING SA (SIX : RLF) announces the proposal of Prof. Jonat.. | BU |
| 2019 | RELIEF THERAPEUTICS : Condensed consolidated interim financial statements for th.. | PU |
| 2019 | RELIEF THERAPEUTICS HOLDING SA : Announces Divestment of its Subsidiary Relief T.. | BU |
| 2019 | RELIEF THERAPEUTICS : announces termination of the agreements with Genclis and H.. | PU |
| 2019 | RELIEF THERAPEUTICS HOLDING AG (SIX : RLF) announces today the results of its An.. | PU |
| 2019 | RELIEF THERAPEUTICS : announces an increase of its capital consecutive to a draw.. | PU |
| 2018 | RELIEF THERAPEUTICS : announces signature of service agreement with Genclis SA | PU |
| 2018 | RELIEF THERAPEUTICS : announces today its financial results for the half-year en.. | PU |
| 2018 | RELIEF THERAPEUTICS : announces significant difference in its 2018 half year fin.. | PU |
| 2018 | RELIEF THERAPEUTICS : announces the prolongation and raise of the amount from th.. | PU |
| 2018 | RELIEF THERAPEUTICS : Holding SA Announces an Out-Licensing Agreement with H&H G.. | BU |
| 2018 | RELIEF THERAPEUTICS HOLDING AG (SIX : RLF) announces the prolongation of its Sha.. | PU |
| 2018 | RELIEF THERAPEUTICS HOLDING AG (SIX : RLF) announces today the results of its An.. | PU |
| 2018 | RELIEF THERAPEUTICS HOLDING AG (SIX : RLF) publishes the agenda for its 2018 Ann.. | PU |
| 2018 | RELIEF THERAPEUTICS : announces today its financial results for the year ended 2.. | PU |
| 2018 | RELIEF THERAPEUTICS : announces today significant difference in its financial re.. | PU |
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
